TrialThe Lancet. Oncology2019

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial.

Howard West et al.PubMed ↗Publisher ↗

No numbers read from the abstract.